KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib


Title:
KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib
Creator:
Varmus, Harold
Miller, Vincent
Kris, Mark
Heelan, Robert
Pao, William
Riely, Gregory J.
Wang, Theresa Y.
Zakowski, Maureen
Ladanyi, Marc
Pan, Qiulu
Date:
January 2005
Description:
This was Varmus's first research article in PLoS, the open-access online publishing venture that he helped to establish in 2000.
Periodical:
PLoS Medicine
Publisher:
Public Library of Science
Rights:
Public Domain
Genre:
Articles
Subject:
Mutation and Lung Neoplasms
Format:
Text
Extent:
5 pages
Language:
English
Legacy Source Citation:
Periodical. Pao, William, Theresa Y. Wang, Gregory J. Riely, Vincent Miller, Qiulu Pan, Marc Ladanyi, Maureen Zakowski, Robert Heelan, Mark Kris, and Harold Varmus. "KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib." PLoS Medicine 2, 1 (January 2005): 57-61. Article. 5 Images.. PLoS Medicine. URL. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC545207/
Legacy ID:
MVBCFB
NLM ID:
101584926X492
Profiles Collection:
The Harold Varmus Papers
Story Section:
Memorial Sloan Kettering Cancer Center, 2000-2010, and National Cancer Institute, 2010-2015